Avita Medical, Inc. (AVHHL) — 8-K Filings

8-K Filings (15)

• AVITA Medical Reports Director/Officer Changes & Compensation — Oct 17, 2025 Risk: medium
  AVITA Medical, Inc. filed an 8-K on October 17, 2025, reporting events as of October 16, 2025. The filing pertains to the departure of directors or certain offi
• AVITA Medical Sells $1.5M in Stock — Aug 18, 2025 Risk: medium
  AVITA Medical, Inc. reported on August 12, 2025, that it entered into a Securities Purchase Agreement on August 12, 2025, for the unregistered sale of 1,000,000
• AVITA Medical Files 8-K — Aug 12, 2025 Risk: low
  AVITA Medical, Inc. filed an 8-K on August 12, 2025, reporting other events and financial statements. The company, formerly known as Avita Therapeutics, Inc. an
• AVITA Medical Files 8-K on Definitive Agreement & Financials — Aug 7, 2025 Risk: medium
  AVITA Medical, Inc. filed an 8-K on August 7, 2025, reporting an entry into a material definitive agreement and updates on its results of operations and financi
• AVITA Medical Announces Director and Officer Changes — Aug 6, 2025 Risk: medium
  AVITA Medical, Inc. announced on August 6, 2025, changes related to its board of directors and executive compensation. Specifically, the company filed an 8-K re
• AVITA Medical Announces Director Changes and Shareholder Votes — Jun 5, 2025 Risk: medium
  AVITA Medical, Inc. announced on June 4, 2025, the departure of Director Dr. Michelle Carpenter and the election of new Director Dr. David L. Smith. The company
• AVITA Medical Files 8-K with Bylaw Amendments — May 15, 2025 Risk: low
  AVITA Medical, Inc. filed an 8-K on May 15, 2025, reporting amendments to its articles of incorporation or bylaws and filing financial statements and exhibits.
• AVITA Medical Enters Material Definitive Agreement — Mar 17, 2025 Risk: medium
  AVITA Medical, Inc. announced on March 17, 2025, that it has entered into a material definitive agreement. The filing does not disclose specific details of the
• AVITA Medical Files 8-K on Financials — Jan 7, 2025 Risk: low
  AVITA Medical, Inc. filed an 8-K on January 7, 2025, reporting on its results of operations and financial condition. The filing includes financial statements an
• AVITA Medical Enters Material Definitive Agreement — Jul 31, 2024 Risk: medium
  AVITA Medical, Inc. announced on July 31, 2024, that it has entered into a material definitive agreement. The company also disclosed information related to Regu
• AVITA Medical Appoints New Chief Medical Officer — Jul 1, 2024 Risk: low
  AVITA Medical, Inc. announced on June 28, 2024, the appointment of Dr. Michael J. R. Hall as Chief Medical Officer, effective immediately. Dr. Hall previously s
• AVITA Medical Appoints New CMO, Elects Directors — Jun 6, 2024 Risk: medium
  AVITA Medical, Inc. announced on June 5, 2024, the appointment of Dr. Michael W. Ryan as Chief Medical Officer and the election of Ms. Jennifer L. Johnson and M
• AVITA Medical to be Acquired by Olatec Therapeutics — May 30, 2024 Risk: medium
  AVITA Medical, Inc. announced on May 29, 2024, that it has entered into a definitive agreement to be acquired by Olatec Therapeutics, LLC. The transaction is ex
• AVITA Medical Files 8-K on Financials — Apr 11, 2024 Risk: low
  AVITA Medical, Inc. filed an 8-K on April 10, 2024, reporting on its results of operations and financial condition. The filing includes financial statements and
• AVITA Medical Files 8-K on Material Agreement, Financials; Details Pending — Jan 10, 2024
  AVITA Medical, Inc. filed an 8-K on January 10, 2024, indicating an "Entry into a Material Definitive Agreement" and disclosing "Results of Operations and Finan

Popular Companies

AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX